1,531
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Efficacity of dupilumab in severe idiopathic cold urticaria: a case report

ORCID Icon &
Article: 2182620 | Received 15 Feb 2023, Accepted 15 Feb 2023, Published online: 23 Feb 2023
 

Disclosure statement

Ziad Reguiai received honoraria from Sanofi and Novartis as a speaker, advisor and investigator in clinical trials.

Data availability statement

The data that support the findings of this study are available from the corresponding author, Z. Reguiai, upon reasonable request.

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.